Skip to main content

Table 2 Distribution of EQ-5D dimensions as reported by patients (N = 416)

From: Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety

    

Baseline

 

End of treatment

 

p value

    

n

%

 

n

%

  

Mobility

         
 

No problems

Slight problems

Moderate problems

Severe problems

Unable to walk about

 

323

78.59

 

364

88.35

 

< 0.001

  

62

15.09

 

39

9.47

  
  

20

4.87

 

9

2.18

  
  

6

1.46

 

.

.

  
  

.

.

 

.

.

  

Self-care

         
 

No problems

Slight problems

Moderate problems

Severe problems

Unable to wash or dress

 

350

85.37

 

398

96.60

 

< 0.001

  

52

12.68

 

11

2.67

  
  

6

1.46

 

2

0.49

  
  

2

0.49

 

1

0.49

  
  

.

.

 

.

.

  

Usual activities

         
 

No problems

Slight problems

Moderate problems

Severe problems

Unable to do usual activities

 

83

20.19

 

258

62.93

 

< 0.001

  

161

39.17

 

111

27.07

  
  

113

27.49

 

35

8.54

  
  

50

12.17

 

6

1.46

  
  

4

0.97

 

.

.

  

Pain / discomfort

         
 

No problems

Slight problems

Moderate problems

Severe problems

Extreme pain or discomfort

 

93

22.63

 

206

50.00

 

< 0.001

  

177

43.07

 

151

36.65

  
  

113

27.49

 

45

10.92

  
  

24

5.84

 

7

1.70

  
  

4

0.97

 

3

0.73

  

Anxiety / depression

         
 

No problems

Slight problems

Moderate problems

Severe problems

Extremely anxious or depressed

 

13

3.17

 

160

38.83

 

< 0.001

  

106

25.85

 

187

44.39

  
  

179

43.66

 

53

12.86

  
  

105

25.61

 

11

2.67

  
  

7

1.71

 

1

0.24

  
  1. Note. Proportion of patients reporting the various levels of severity on the EQ-5D dimensions at baseline, and at end of treatment. The P-values denote significance of a non-parametric test of trends across ordered groups, developed by Cuzick, similar to the Wilcoxon rank-sum test [35]